Market Indices
Latest News
 |
| ||
| ||
| ||
|
Price Targets
from Cowen & Co. issued a price target of $11.00 for ALLT on 2026-02-25 20:14:22.The adjusted price target was set to $11.00.At the time of the announcement,
February 25, 2026 ALLT -31.09%
from Industrial Alliance Securities issued a price target of $2.50 for OPAD on 2026-02-24 18:25:53.The adjusted price target was set to $2.50.At the time of the announcement,
February 24, 2026 OPAD 11.00%
Yi Chen from H.C. Wainwright issued a price target of $12.00 for DRTS on 2026-02-24 15:29:33.The adjusted price target was set to $12.00.At the time of the announcement,
February 24, 2026 DRTS 13.59%
from Wedbush issued a price target of $1.00 for GOSS on 2026-02-24 12:45:05.The adjusted price target was set to $1.00.At the time of the announcement, GOSS was...
February 24, 2026 GOSS -10.11%
from Leerink Partners issued a price target of $50.00 for XOMA on 2026-02-24 11:08:45.The adjusted price target was set to $50.00.At the time of the announcement, XOMA...
February 24, 2026 XOMA -0.70%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| LRMR Larimar Therapeutics, Inc | 6.01
62.74% | ||||||||||||||||||
| RYAM Rayonier Advanced Materia | 10.31
43.69% | ||||||||||||||||||
| RCKY Rocky Brands, Inc. | 46.00
37.35% | ||||||||||||||||||
| DRTSW Alpha Tau Medical Ltd. Wa | 1.47
23.53% | ||||||||||||||||||
| ASPS Altisource Portfolio Solu | 8.62
21.73% | ||||||||||||||||||
| ATRA Atara Biotherapeutics, In | 5.02
19.12% | ||||||||||||||||||
| CDIOW Cardio Diagnostics Holdin | 0.05
18.68% | ||||||||||||||||||
| CCCC C4 Therapeutics, Inc. | 2.80
16.95% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP 8.71%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -3.22%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK -0.21%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 2.59%